#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	17078	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2610	804.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1789	1789	C	1051	C,G	1050,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28998	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4020	898.8	0	.	n	.	0	T695C	SNP	695	695	T	1247	1247	C	1091	C,G	1088,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28998	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4020	898.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1889	1889	A	1177	A,G	1176,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28998	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4020	898.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2523	2523	C	1083	C,T	1081,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28998	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4020	898.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2597	2597	A	1006	A,G	1001,3	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28998	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4020	898.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	3149	3149	C	1042	C,T,G	1038,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2322	folP	855	855	100.0	folP.l15.c4.ctg.1	2053	141.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1286	1288	AGC	232;234;233	A;G;C	232;234;233	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5790	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3985	181.3	1	SNP	p	S91F	1	.	.	271	273	TTC	889	891	TTC	203;203;204	T;T;C	203;203;204	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5790	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3985	181.3	1	SNP	p	D95G	1	.	.	283	285	GGC	901	903	GGC	215;215;215	G;G;C	215;215;215	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5790	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3985	181.3	1	SNP	p	G95N	0	.	.	283	285	GGC	901	903	GGC	215;215;215	G;G;C	215;215;215	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	2328	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1835	158.3	1	SNP	p	G45D	0	.	.	133	135	GGC	741	743	GGC	258;252;251	G,T,A;G,A;C,A	256,1,1;251,1;249,2	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1142	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1557	91.5	0	.	n	.	0	A197.	DEL	197	197	A	868	868	A	227	A	227	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5672	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3472	203.3	1	SNP	p	D86N	0	.	.	256	258	GAC	866	868	GAC	227;229;228	G;A,C;C	226;227,1;228	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5672	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3472	203.3	1	SNP	p	R87W	0	.	.	259	261	CGT	869	871	CGT	230;232;233	C;G;T	230;232;233	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5672	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3472	203.3	1	SNP	p	S87R	1	.	.	259	261	CGT	869	871	CGT	230;232;233	C;G;T	230;232;233	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5672	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3472	203.3	1	SNP	p	R87I	0	.	.	259	261	CGT	869	871	CGT	230;232;233	C;G;T	230;232;233	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5672	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3472	203.3	1	SNP	p	S88P	0	.	.	262	264	TCC	872	874	TCC	235;231;230	T,C,G;C;C,G	233,1,1;231;229,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4850	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3131	193.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1818	1820	GGC	261;256;251	G;G;C,T	261;256;250,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4620	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2940	196.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1548	1550	GCA	285;288;281	G,A;C;A	284,1;288;281	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4620	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2940	196.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1551	1553	ATC	280;279;275	A;T;C	280;279;275	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4620	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2940	196.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1563	1565	GTG	285;285;281	G,T;T;G,A	284,1;285;280,1	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4620	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2940	196.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1563	1565	GTG	285;285;281	G,T;T;G,A	284,1;285;280,1	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4620	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2940	196.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2067	2069	ACC	239;241;242	A;C,T;C	239;240,1;242	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4620	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2940	196.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2121	2123	GCG	247;249;251	G,C;C;G	246,1;249;251	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4620	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2940	196.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2121	2123	GCG	247;249;251	G,C;C;G	246,1;249;251	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4620	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2940	196.1	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2244	2246	AGC	248;248;249	A,T;G;C	247,1;248;249	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4620	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2940	196.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2253	2255	GGC	247;246;250	G;G,C;C,T	247;245,1;249,1	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4620	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2940	196.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2271	2273	CCG	244;249;245	C,G,A;C,T;G	241,2,1;248,1;245	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6450	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3554	226.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1865	1867	CCG	276;274;276	C,T;C,G;G,A	275,1;273,1;275,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2596	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2317	139.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	846	846	C	202	C	202	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	320	porB1a	984	226	90.27	porB1a.l15.c4.ctg.1	583	22.5	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	23;27;29	T;T;A	23;27;29	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	320	porB1a	984	226	90.27	porB1a.l15.c4.ctg.1	583	22.5	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	66;66;66	C;A;T	66;66;66	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	320	porB1a	984	226	90.27	porB1a.l15.c4.ctg.1	583	22.5	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	66;66;66	A;G;T	66;66;66	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	320	porB1a	984	226	90.27	porB1a.l15.c4.ctg.1	583	22.5	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	66;66;66	T;A,G;C	66;65,1;66	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	320	porB1a	984	226	90.27	porB1a.l15.c4.ctg.1	583	22.5	0	.	p	.	0	R307A	NONSYN	919	921	AGA	161	163	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	320	porB1a	984	226	90.27	porB1a.l15.c4.ctg.1	583	22.5	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	320	porB1a	984	226	90.27	porB1a.l15.c4.ctg.1	583	22.5	0	.	p	.	0	E312D	NONSYN	934	936	GAA	176	178	GAC	1;1;1	G;A;C	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	320	porB1a	984	226	90.27	porB1a.l15.c4.ctg.1	583	22.5	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	1;1;1	A;T;C	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	320	porB1a	984	226	90.27	porB1a.l15.c4.ctg.1	583	22.5	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	2;2;2	T;C;G	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	320	porB1a	984	226	90.27	porB1a.l15.c4.ctg.1	583	22.5	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	2;2;2	G;C;C	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	320	porB1a	984	226	90.27	porB1a.l15.c4.ctg.1	583	22.5	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	2;2;2	A;G;C	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	320	porB1a	984	226	90.27	porB1a.l15.c4.ctg.1	583	22.5	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	2;2;2	G;C;C	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	320	porB1a	984	226	90.27	porB1a.l15.c4.ctg.1	583	22.5	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	1;1;1	G;T;T	1;1;1	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3298	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1828	222.6	0	.	p	.	0	V75I	NONSYN	223	225	GTT	653	655	ATT	273;272;270	A;T,C,A;T	273;270,1,1;270	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3298	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1828	222.6	0	.	p	.	0	T89S	NONSYN	265	267	ACC	695	697	AGC	257;258;263	A,C;G;C	256,1;257;262	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3298	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1828	222.6	0	.	p	.	0	V98I	NONSYN	292	294	GTC	722	724	ATC	245;245;243	A,G;T;C	244,1;245;243	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3298	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1828	222.6	0	.	p	.	0	.	MULTIPLE	358	359	AA	787	788	CG	248;249	C;G,A	248;248,1	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3298	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1828	222.6	0	.	p	.	0	.	MULTIPLE	361	362	GA	790	792	CAG	250;247;250	C;A;G	250;247;250	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3298	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1828	222.6	0	.	p	.	0	N122K	NONSYN	364	366	AAC	794	796	AAA	246;252;250	A,G;A,T;A,G	245,1;250,1;248,1	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3298	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1828	222.6	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	821	823	TAT	282;281;276	T,G,C;A,G;T,G	278,2,2;280,1;275,1	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3298	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1828	222.6	0	.	p	.	0	N134E	NONSYN	400	402	AAT	830	832	GAG	277;277;280	G;A;G	277;277;280	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3298	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1828	222.6	0	.	p	.	0	V135L	NONSYN	403	405	GTG	833	835	CTT	278;278;280	C;T;T	278;278;280	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3298	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1828	222.6	0	.	p	.	0	G140K	NONSYN	418	420	GGA	848	850	AAA	280;280;279	A;A;A	280;279;278	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3298	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1828	222.6	0	.	p	.	0	Q143E	NONSYN	427	429	CAA	857	859	GAA	284;285;283	G,T;A;A	282,1;284;282	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3298	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1828	222.6	0	.	p	.	0	A213S	NONSYN	637	639	GCA	1067	1069	TCA	303;300;300	T,A;C;A	302,1;300;299	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3298	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1828	222.6	0	.	p	.	0	Y255W	NONSYN	763	765	TAC	1193	1195	TGG	341;343;340	T;G,A;G,T	341;342,1;339,1	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3298	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1828	222.6	0	.	p	.	0	E326A	NONSYN	976	978	GAA	1406	1408	GCA	291;292;294	G;C,G;A,C	291;291,1;293,1	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3298	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1828	222.6	1	SNP	p	G120K	1	.	.	358	360	AAG	787	789	CGG	248;249;250	C;G,A;G	248;248,1;250	porB1b.WHO_X_02194c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3298	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1828	222.6	1	SNP	p	D121N	0	.	.	361	363	GAC	790	793	CGC	250;250;250	C;G;CAAA,CAA	250;250;233,1	porB1b.WHO_X_02194c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3298	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1828	222.6	1	SNP	p	A121D	1	.	.	361	363	GAC	790	793	CGC	250;250;250	C;G;CAAA,CAA	250;250;233,1	porB1b.WHO_X_02194c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11116	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5347	258.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1636	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1594	127.9	1	SNP	p	V57M	1	.	.	169	171	ATG	734	736	ATG	293;293;293	A;T;G	293;293;293	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
